Philips Nederland B.V.

Philips Nederland B.V. specializes in in vitro diagnostic (IVD) systems under the LABOSYS brand. These devices are designed for laboratory automation and analysis, helping streamline clinical workflows by processing and analyzing biological samples like blood and other specimens. The focus is on supporting diagnostic testing in healthcare settings.

Philips Nederland B.V. is headquartered in the Netherlands, which places it within the European Union’s regulatory framework. Since its devices fall under IVD General classification, they must comply with EU regulations, including registration in the eudamed database—a central EU repository for IVD information. This ensures alignment with EU requirements for device safety, performance, and traceability.

Philips Nederland B.V.’s devices are listed in the eudamed database, the official EU registry for in vitro diagnostic (IVD) devices. This registry is critical because it provides transparency on device details (e.g., manufacturer, classification, and regulatory status) to healthcare professionals, regulators, and authorities. Listing in eudamed ensures compliance with EU MDR (Medical Device Regulation) requirements and facilitates traceability for post-market surveillance.

Philips Nederland B.V.’s devices are classified under IVD General, which means they are considered lower-risk in vitro diagnostics. This classification determines the regulatory pathway, including documentation requirements and conformity assessment procedures. While IVD General devices undergo rigorous testing for accuracy and safety, they typically require less stringent post-market surveillance than higher-risk classes (e.g., Class C or D). The classification ensures they meet essential performance standards for clinical use.